Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Retrospective Study to Characterise Patients Receiving Benralizumab in the Framework of an Individualized Access Program in Spain

NCT04126499 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04126499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04126499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Retrospective Study to Characterise Patients Receiving Benralizumab in the Framework of an Individualized Access Program in Spain
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
January 13, 2020
Completion date
May 8, 2020
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe eosinophilic asthma